statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.102
DE - Germania	386
CN - Cina	153
SG - Singapore	152
IT - Italia	145
VN - Vietnam	72
BD - Bangladesh	66
BR - Brasile	49
HK - Hong Kong	49
GB - Regno Unito	30
RU - Federazione Russa	27
SE - Svezia	27
NL - Olanda	25
FR - Francia	24
IN - India	22
CI - Costa d'Avorio	21
CA - Canada	19
FI - Finlandia	11
ES - Italia	8
AR - Argentina	6
ID - Indonesia	6
IE - Irlanda	6
KR - Corea	6
JP - Giappone	5
TR - Turchia	5
UA - Ucraina	5
ZA - Sudafrica	5
PL - Polonia	4
CO - Colombia	3
IR - Iran	3
AT - Austria	2
GT - Guatemala	2
IQ - Iraq	2
LT - Lituania	2
MA - Marocco	2
MX - Messico	2
NP - Nepal	2
PH - Filippine	2
PK - Pakistan	2
SA - Arabia Saudita	2
SK - Slovacchia (Repubblica Slovacca)	2
AF - Afghanistan, Repubblica islamica di	1
BE - Belgio	1
BH - Bahrain	1
BY - Bielorussia	1
CH - Svizzera	1
CR - Costa Rica	1
EG - Egitto	1
JO - Giordania	1
KG - Kirghizistan	1
MK - Macedonia	1
MM - Myanmar	1
MY - Malesia	1
NE - Niger	1
PS - Palestinian Territory	1
PT - Portogallo	1
SC - Seychelles	1
SY - Repubblica araba siriana	1
TW - Taiwan	1
UZ - Uzbekistan	1
YE - Yemen	1
Totale	2.484

Nome	#
AZD1775: effect of monotherapy or EDP-M combination in the treatment of ACC preclinical models	453
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant	430
A novel mechanism regulating dopamine receptor type 2 (DRD2) signal transduction in pituitary tumoral cells: the role of cAMP/PKA-induced filamin A (FLNA) phosphorylation	383
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth	323
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells	244
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs	175
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells	138
Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma	126
The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells	100
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs	89
Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells	85
Totale	2.546

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	5	0	0	0	0	0	0	0	0	0	0	0	5
2021/2022	411	1	4	16	39	59	67	53	38	61	38	19	16
2022/2023	104	14	6	4	4	4	30	5	12	13	1	8	3
2023/2024	99	7	3	4	11	39	2	15	2	0	4	5	7
2024/2025	254	9	6	4	24	16	14	9	30	14	36	37	55
2025/2026	1.656	81	708	107	116	92	39	123	44	113	75	113	45
Totale													2.546

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca